Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Viswanathan, Srinivas R"'
Autor:
Alesi N; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Akl EW; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Khabibullin D; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Liu HJ; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Nidhiry AS; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Garner ER; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Filippakis H; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Lam HC; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Shi W; Department of Surgery, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Viswanathan SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Morroni M; Department of Experimental and Clinical Medicine, Section of Neuroscience and Cell Biology, School of Medicine, Università Politecnica delle Marche, Ancona, Italy.; Electron Microscopy Unit, Azienda Ospedaliero-Universitaria, Ancona, Italy., Ferguson SM; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.; Department of Neuroscience, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA., Henske EP; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. EHENSKE@BWH.HARVARD.EDU.
Publikováno v:
Nature communications [Nat Commun] 2021 Jul 12; Vol. 12 (1), pp. 4245. Date of Electronic Publication: 2021 Jul 12.
Autor:
Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shukla SA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Pan W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gao X; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Hou Y; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Flaifel A; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Tang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bosma-Moody A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Vokes N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nyman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xie W; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Nassar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Abou Alaiwi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Flippot R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bouchard G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Steinharter JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ficial M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Sant'Angelo M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dudani S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Camp S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sticco-Ivins M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Hirsch L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wind-Rotolo M; Bristol-Myers Squibb, Princeton, NJ, USA., Ross-Macdonald P; Bristol-Myers Squibb, Princeton, NJ, USA., Sun M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chang SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wei XX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Harshman LC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Genovese G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ellis L; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Atkins MB; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ho TH; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Linehan WM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., McDermott DF; Beth Israel Deaconess Medical Center, Boston, MA, USA., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Viswanathan SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Toni_Choueiri@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2021 Feb 05; Vol. 12 (1), pp. 808. Date of Electronic Publication: 2021 Feb 05.